nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—Parkinson's disease	0.967	1	CbGaD
Regadenoson—ADORA2A—Activation of TRKA receptors—NGF—Parkinson's disease	0.00281	0.109	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—DBH—Parkinson's disease	0.00249	0.0967	CbGpPWpGaD
Regadenoson—Adenosine monophosphate—FBP1—Parkinson's disease	0.00169	0.221	CrCbGaD
Regadenoson—Adenosine triphosphate—ADRBK2—Parkinson's disease	0.00147	0.192	CrCbGaD
Regadenoson—ADORA2A—Monoamine Transport—SLC6A3—Parkinson's disease	0.00102	0.0396	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—TH—Parkinson's disease	0.00102	0.0396	CbGpPWpGaD
Regadenoson—Adenosine triphosphate—HSPA1A—Parkinson's disease	0.00102	0.133	CrCbGaD
Regadenoson—Vidarabine—ADORA2A—Parkinson's disease	0.000865	0.113	CrCbGaD
Regadenoson—Adenosine triphosphate—ADRBK1—Parkinson's disease	0.000803	0.105	CrCbGaD
Regadenoson—Adenosine—ADORA2A—Parkinson's disease	0.000692	0.0904	CrCbGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000551	0.0214	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—RIT2—Parkinson's disease	0.000528	0.0205	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—DRD3—Parkinson's disease	0.00048	0.0186	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000472	0.0184	CbGpPWpGaD
Regadenoson—S-Adenosylmethionine—COMT—Parkinson's disease	0.000461	0.0603	CrCbGaD
Regadenoson—ADORA2A—GPCRs, Other—HTR7—Parkinson's disease	0.000434	0.0169	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—DDC—Parkinson's disease	0.00042	0.0163	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—IL1B—Parkinson's disease	0.000416	0.0161	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—RIT2—Parkinson's disease	0.000406	0.0158	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—DRD1—Parkinson's disease	0.000387	0.015	CbGpPWpGaD
Regadenoson—Adenosine triphosphate—ABL1—Parkinson's disease	0.000376	0.0491	CrCbGaD
Regadenoson—ADORA2A—GPCR ligand binding—GPR37—Parkinson's disease	0.00036	0.014	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—HTR7—Parkinson's disease	0.000339	0.0132	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—MAG—Parkinson's disease	0.000327	0.0127	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF20—Parkinson's disease	0.000317	0.0123	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000304	0.0118	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—HTR2A—Parkinson's disease	0.000304	0.0118	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—TNF—Parkinson's disease	0.000302	0.0117	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000278	0.0108	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—DRD1—Parkinson's disease	0.000263	0.0102	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—DRD3—Parkinson's disease	0.000255	0.00989	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—GRM4—Parkinson's disease	0.000245	0.0095	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—FGF20—Parkinson's disease	0.000244	0.00948	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—TH—Parkinson's disease	0.000234	0.0091	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—ADRBK1—Parkinson's disease	0.000233	0.00906	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—PENK—Parkinson's disease	0.000232	0.00901	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—DRD2—Parkinson's disease	0.00023	0.00894	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—HTR7—Parkinson's disease	0.00023	0.00894	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000223	0.00866	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000215	0.00836	CbGpPWpGaD
Regadenoson—S-Adenosylmethionine—CYP2E1—Parkinson's disease	0.000215	0.0281	CrCbGaD
Regadenoson—ADORA2A—GPCR ligand binding—PDYN—Parkinson's disease	0.000212	0.00824	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000209	0.0081	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000203	0.0079	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—GRM5—Parkinson's disease	0.000197	0.00766	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000191	0.00742	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000189	0.00732	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000189	0.00732	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000188	0.00731	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GPR37—Parkinson's disease	0.000185	0.00717	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—DGKQ—Parkinson's disease	0.000185	0.00717	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000184	0.00717	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—ADRBK1—Parkinson's disease	0.000179	0.00696	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000179	0.00694	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000169	0.00656	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—Parkinson's disease	0.000166	0.00645	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000162	0.00628	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000162	0.00628	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GRK5—Parkinson's disease	0.000154	0.00599	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—HTR1A—Parkinson's disease	0.000145	0.00565	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—TAC1—Parkinson's disease	0.000143	0.00556	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—DRD1—Parkinson's disease	0.00014	0.00546	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GRK5—Parkinson's disease	0.00014	0.00544	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GRM4—Parkinson's disease	0.000138	0.00537	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—DRD3—Parkinson's disease	0.000136	0.00528	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000132	0.00513	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VPS35—Parkinson's disease	0.000132	0.00511	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PENK—Parkinson's disease	0.000131	0.00509	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000129	0.00502	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NGF—Parkinson's disease	0.000128	0.00496	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GRM4—Parkinson's disease	0.000126	0.00488	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—DRD2—Parkinson's disease	0.000123	0.00478	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—HTR7—Parkinson's disease	0.000123	0.00478	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PDYN—Parkinson's disease	0.00012	0.00465	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PENK—Parkinson's disease	0.000119	0.00462	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000113	0.0044	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GRM5—Parkinson's disease	0.000111	0.00433	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DGKQ—Parkinson's disease	0.000109	0.00424	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GPR37—Parkinson's disease	0.000109	0.00424	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PDYN—Parkinson's disease	0.000109	0.00423	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GRM5—Parkinson's disease	0.000101	0.00393	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PPP1R1B—Parkinson's disease	9.98e-05	0.00387	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—EDN1—Parkinson's disease	9.85e-05	0.00383	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—MAPK8—Parkinson's disease	8.76e-05	0.0034	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RIT2—Parkinson's disease	8.72e-05	0.00339	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—HTR2A—Parkinson's disease	8.62e-05	0.00335	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GRK5—Parkinson's disease	8.27e-05	0.00321	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	8.22e-05	0.00319	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—TAC1—Parkinson's disease	8.09e-05	0.00314	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—DRD1—Parkinson's disease	7.94e-05	0.00308	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—DRD3—Parkinson's disease	7.69e-05	0.00299	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR1A—Parkinson's disease	7.46e-05	0.0029	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GRM4—Parkinson's disease	7.41e-05	0.00288	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—TAC1—Parkinson's disease	7.35e-05	0.00286	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—DRD1—Parkinson's disease	7.21e-05	0.0028	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CASP3—Parkinson's disease	7.19e-05	0.00279	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.18e-05	0.00279	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PENK—Parkinson's disease	7.03e-05	0.00273	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MAG—Parkinson's disease	7.03e-05	0.00273	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—DRD3—Parkinson's disease	6.98e-05	0.00271	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—DRD2—Parkinson's disease	6.95e-05	0.0027	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR7—Parkinson's disease	6.95e-05	0.0027	CbGpPWpGaD
Regadenoson—Adenosine triphosphate—ABCB1—Parkinson's disease	6.95e-05	0.00909	CrCbGaD
Regadenoson—ADORA2A—Signaling by NGF—MAPK8—Parkinson's disease	6.61e-05	0.00257	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	6.52e-05	0.00253	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDYN—Parkinson's disease	6.43e-05	0.0025	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—DRD2—Parkinson's disease	6.31e-05	0.00245	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR7—Parkinson's disease	6.31e-05	0.00245	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GFAP—Parkinson's disease	6.04e-05	0.00235	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GRM5—Parkinson's disease	5.98e-05	0.00232	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—IL6—Parkinson's disease	5.6e-05	0.00217	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—EDN1—Parkinson's disease	5.57e-05	0.00216	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	5.49e-05	0.00213	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FGF20—Parkinson's disease	5.24e-05	0.00204	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EDN1—Parkinson's disease	5.05e-05	0.00196	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	4.87e-05	0.00189	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—INSR—Parkinson's disease	4.69e-05	0.00182	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FGB—Parkinson's disease	4.43e-05	0.00172	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR2A—Parkinson's disease	4.42e-05	0.00172	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR1A—Parkinson's disease	4.41e-05	0.00171	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TAC1—Parkinson's disease	4.34e-05	0.00169	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DRD1—Parkinson's disease	4.26e-05	0.00165	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—IL6—Parkinson's disease	4.22e-05	0.00164	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DRD3—Parkinson's disease	4.12e-05	0.0016	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADRBK1—Parkinson's disease	3.85e-05	0.0015	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DRD2—Parkinson's disease	3.73e-05	0.00145	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR7—Parkinson's disease	3.73e-05	0.00145	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF2—Parkinson's disease	3.13e-05	0.00121	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF1R—Parkinson's disease	3.02e-05	0.00117	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDN1—Parkinson's disease	2.99e-05	0.00116	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGF—Parkinson's disease	2.74e-05	0.00107	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.61e-05	0.00101	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOE—Parkinson's disease	2.43e-05	0.000943	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—INS—Parkinson's disease	2.07e-05	0.000806	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CASP3—Parkinson's disease	1.54e-05	0.0006	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6—Parkinson's disease	1.53e-05	0.000596	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.42e-05	0.000551	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6—Parkinson's disease	9.06e-06	0.000352	CbGpPWpGaD
